ACMR
ACM Research, Inc.
ACMR's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over ACMR overall, supported by stronger fundamentals and stronger valuation.
ACMR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Weak | |
| Healthy |
ACMR's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
ACMR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $24.47 | -51% |
| Forward | 18x | $49.88 | — |
| Fair | 26x | $41.77 | -16% |
| Current | 31x | $49.88 | — |
| Expensive | 74x | $119 | +139% |
Historical ranges are pointers, not guarantees.
ACMR's PE is in its fair range at 31x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over ACMR in the historical PE scenario, which offers more potential upside but is not a forecast.
ACMR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for ACMR, with profitability improving.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
ACMR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.80 | +75% |
| Q3 2026 | $1.60 | -7.5% |
| Q2 2026 | $2.10 | +27% |
| Q1 2026 | $1.31 | -17% |
| Q4 2025 | $1.37 | -10% |
| Q3 2025 | $1.73 | +32% |
| Q2 2025 | $1.66 | +33% |
| Q1 2025 | $1.57 | +20% |
| Q4 2024 | $1.53 | +32% |
ACMR earned $1.60 per share over the past year, down 7.5% from the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over ACMR on earnings, with more consistent year-over-year improvement.
ACMR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $367.7M | +37% |
| Q2 2026 | $292.9M | +36% |
| Q1 2026 | $231.3M | +34% |
| Q4 2025 | $244.4M | +9.4% |
| Q3 2025 | $269.2M | +32% |
| Q2 2025 | $215.4M | +6.4% |
| Q1 2025 | $172.3M | +13% |
| Q4 2024 | $223.5M | +31% |
ACMR's revenue has grown year over year for 18 quarters in a row: $368M last quarter, up 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +4.3 points |
| Q2 2026 | 17% | +2.3 points |
| Q1 2026 | 16% | +0.7 points |
| Q4 2025 | 9.4% | -10 points |
| Q3 2025 | 11% | -11 points |
| Q2 2025 | 15% | -3.8 points |
| Q1 2025 | 15% | -1.6 points |
| Q4 2024 | 20% | +6 points |
ACMR's operating margin was 15% last quarter, up 4.3 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over ACMR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over ACMR on profitability, with a higher operating margin.
ACMR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$95.6M | -$80M |
| Q2 2026 | -$71.5M | -$11.8M |
| Q1 2026 | -$51.7M | -$40.3M |
| Q4 2025 | $20.1M | -74% |
| Q3 2025 | -$15.6M | +$5M |
| Q2 2025 | -$59.6M | -223% |
| Q1 2025 | -$11.4M | +$23.6M |
| Q4 2024 | $77.2M | +$122.7M |
ACMR has burned cash in most quarters: −$199M over the past year, against −$10M the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over ACMR on cash generation, producing positive trailing cash flow while its opponent burns cash.
ACMR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +1.8M shares |
| 1 year | +7.6% | +5.2M shares |
| 3 years | +12% | +8.2M shares |
| 5 years | +13% | +8.2M shares |
| Available history | +28% | +16.2M shares |
ACMR has 74M diluted shares, up 7.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2020 | — |
| Q4 2019 | $2M |
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has the edge over ACMR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
ACMR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.9x | Net Cash |
| Q2 2026 | -4.0x | Net Cash |
| Q1 2026 | -4.0x | Net Cash |
| Q4 2025 | -3.8x | Net Cash |
| Q3 2025 | -5.6x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.5x | Net Cash |
| Q4 2024 | -1.4x | Net Cash |
ACMR has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
ACMR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.7 | Neutral |
| Stochastic | 13.7 | Oversold |
ACMR's weekly RSI is 40 (neutral) and its Stochastic is 14 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
ACMR PE vs Technology Sector
| Metric | ACMR | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 28x | 12% above |
| PE % | 54 | 35 | 19 pts above |
ACMR is trading at 31x earnings, a 12% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over ACMR on valuation relative to its sector.
ACMR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $59.5 | 16% below |
| 20 week MA | $72.8 | 31% below |
| 50 week MA | $64.2 | 22% below |
| 100 week MA | $45.4 | 10% above |
| 200 week MA | $31.5 | 58% above |
ACMR has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 58% above its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over ACMR on trend strength, trading above more of its moving averages.
ACMR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.13 | $23.2 | +279% |
| 2021 | $23.2 | $25.9 | +11% |
| 2022 | $25.9 | $7.52 | -71% |
| 2023 | $7.52 | $19.5 | +160% |
| 2024 | $19.5 | $15.2 | -22% |
| 2025 | $15.2 | $40.6 | +167% |
| 2026 YTD | $40.6 | $49.9 | +23% |
ACMR's yearly returns have swung widely, from +279% in 2020 to −71% in 2022. It's up 23% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over ACMR on returns for 2026, with the stronger performance.